Literature DB >> 1922004

Molecular control of myogenesis: antagonism between growth and differentiation.

E N Olson1, T J Brennan, T Chakraborty, T C Cheng, P Cserjesi, D Edmondson, G James, L Li.   

Abstract

Insight into the molecular mechanisms that control establishment of the skeletal muscle phenotype has recently been obtained through cloning of a family of muscle-specific regulatory factors that can activate myogenesis when transfected into non-muscle cells. This family of factors, which includes MyoD, myogenin, myf-5, and MRF4, can bind DNA and transactivate muscle-specific genes in collaboration with ubiquitous cellular factors. Growth factors play an antagonistic role in myogenesis by suppressing the actions of the myogenic regulatory factor family. This review will focus on the regulation and mechanism of action of this family of myogenic regulatory factors and on the central role of peptide growth factors in modulating their expression and biological activities.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1922004     DOI: 10.1007/bf00229797

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  35 in total

1.  The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation.

Authors:  R L Davis; P F Cheng; A B Lassar; H Weintraub
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

2.  Cell proliferation inhibited by MyoD1 independently of myogenic differentiation.

Authors:  V Sorrentino; R Pepperkok; R L Davis; W Ansorge; L Philipson
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

3.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

Authors:  C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

4.  A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program.

Authors:  D G Edmondson; E N Olson
Journal:  Genes Dev       Date:  1989-05       Impact factor: 11.361

5.  Effect of cell history on response to helix-loop-helix family of myogenic regulators.

Authors:  B W Schäfer; B T Blakely; G J Darlington; H M Blau
Journal:  Nature       Date:  1990-03-29       Impact factor: 49.962

6.  Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene.

Authors:  J N Buskin; S D Hauschka
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

7.  Myf-6, a new member of the human gene family of myogenic determination factors: evidence for a gene cluster on chromosome 12.

Authors:  T Braun; E Bober; B Winter; N Rosenthal; H H Arnold
Journal:  EMBO J       Date:  1990-03       Impact factor: 11.598

8.  Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase and is repressed by fibroblast growth factor.

Authors:  C H Clegg; T A Linkhart; B B Olwin; S D Hauschka
Journal:  J Cell Biol       Date:  1987-08       Impact factor: 10.539

9.  Regulation of myogenic differentiation by type beta transforming growth factor.

Authors:  E N Olson; E Sternberg; J S Hu; G Spizz; C Wilcox
Journal:  J Cell Biol       Date:  1986-11       Impact factor: 10.539

10.  Dexamethasone-dependent inhibition of differentiation of C2 myoblasts bearing steroid-inducible N-ras oncogenes.

Authors:  L A Gossett; W Zhang; E N Olson
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

View more
  15 in total

1.  The MRF4 activation domain is required to induce muscle-specific gene expression.

Authors:  K L Mak; R Q To; Y Kong; S F Konieczny
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

Review 2.  Cellular and molecular events controlling skeletal muscle mass in response to altered use.

Authors:  François B Favier; Henri Benoit; Damien Freyssenet
Journal:  Pflugers Arch       Date:  2008-01-12       Impact factor: 3.657

3.  Pias1 is essential for erythroid and vascular development in the mouse embryo.

Authors:  Jerfiz D Constanzo; Mi Deng; Smita Rindhe; Ke-Jing Tang; Cheng-Cheng Zhang; Pier Paolo Scaglioni
Journal:  Dev Biol       Date:  2016-05-04       Impact factor: 3.582

4.  Skeletal muscle mass recovery from atrophy in IL-6 knockout mice.

Authors:  T A Washington; J P White; J M Davis; L B Wilson; L L Lowe; S Sato; J A Carson
Journal:  Acta Physiol (Oxf)       Date:  2011-04-27       Impact factor: 6.311

5.  Trichinella spiralis-infected muscle cells: abundant RNA polymerase II in nuclear speckle domains colocalizes with nuclear antigens.

Authors:  C Yao; D P Jasmer
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 6.  The regulation of gene expression in hair cells.

Authors:  Allen F Ryan; Ryoukichi Ikeda; Masatsugu Masuda
Journal:  Hear Res       Date:  2015-01-21       Impact factor: 3.208

7.  Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors.

Authors:  Y Kong; S E Johnson; E J Taparowsky; S F Konieczny
Journal:  Mol Cell Biol       Date:  1995-10       Impact factor: 4.272

8.  Down-regulation of myogenin can reverse terminal muscle cell differentiation.

Authors:  Nikolaos P Mastroyiannopoulos; Paschalis Nicolaou; Mustafa Anayasa; James B Uney; Leonidas A Phylactou
Journal:  PLoS One       Date:  2012-01-03       Impact factor: 3.240

9.  Cadherins promote skeletal muscle differentiation in three-dimensional cultures.

Authors:  A Redfield; M T Nieman; K A Knudsen
Journal:  J Cell Biol       Date:  1997-09-22       Impact factor: 10.539

10.  Uncoupling of growth inhibition and differentiation in dexamethasone-treated human rhabdomyosarcoma cells.

Authors:  C De Giovanni; P L Lollini; R Dolcetti; L Landuzzi; G Nicoletti; E D'Andrea; K Scotland; P Nanni
Journal:  Br J Cancer       Date:  1993-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.